Publications
Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy
Cohen Saban, N,
Yalin, A,
Landsberger, T,
Salomon, R,
Alva, A,
Feferman, T,
Amit, I,
Dahan, R,
Sci Immunol, 2023 Mar; DOI:10.1126/sciimmunol.add8005 Neoadjuvant-Adjuvant or Adjuvant-Only Pembrolizumab in Advanced Melanoma
Patel, SP,
Othus, M,
Chen, Y,
Wright, GP,
Yost, KJ,
Hyngstrom, JR,
Hu-Lieskovan, S,
Lao, CD,
Fecher, LA,
Truong, T-G,
Eisenstein, JL,
Chandra, S,
Sosman, JA,
Kendra, KL,
Wu, RC,
Devoe, CE,
Deutsch, GB,
Hegde, A,
Khalil, M,
Mangla, A,
Reese, AM,
Ross, MI,
Poklepovic, AS,
Phan, GQ,
Onitilo, AA,
Yasar, DG,
Powers, BC,
Doolittle, GC,
In, GK,
Kokot, N,
Gibney, GT,
Atkins, MB,
Shaheen, M,
Warneke, JA,
Ikeguchi, A,
Najera, JE,
Chmielowski, B,
Crompton, JG,
Floyd, JD,
Hsueh, E,
Margolin, KA,
Chow, WA,
Grossmann, KF,
Dietrich, E,
Prieto, VG,
Lowe, MC,
Buchbinder, EI,
Kirkwood, JM,
Korde, L,
Moon, J,
Sharon, E,
Sondak, VK,
Ribas, A,
N Engl J Med, 2023 Mar; DOI:10.1056/NEJMoa2211437 Differential adoption of castration-resistant prostate cancer treatment across facilities in a national healthcare system
Caram, MEV,
Kumbier, K,
Burns, J,
Sparks, JB,
Tsao, PA,
Stensland, KD,
Washington, SL,
Hollenbeck, BK,
Shahinian, V,
Skolarus, TA,
Cancer Med, 2023 Mar; DOI:10.1002/cam4.5490 Two cases of challenging cutaneous lymphoid infiltrates presenting in the context of COVID-19 vaccination: a reactive lymphomatoid papulosis‐like eruption and a bona fide lymphoma
Bresler, SC,
Menge, TD,
Tejasvi, T,
Carty, SA,
Hristov, AC,
J Cutan Pathol, 2023 Mar; DOI:10.1111/cup.14371 Abstract P1-09-05: Effect of Wire vs Magnetic Seed Localization on Lumpectomy Cavity Size
Dykstra, M,
Thompson, J,
Aldous, J,
Jiang, S,
Hughes, T,
Hayman, J,
Dragovic, A,
Shah, J,
Chang, A,
Speers, CW,
Sabel, M,
Dossett, L,
Schipper, M,
Jagsi, R,
Cancer Research, 2023 Mar; DOI:10.1158/1538-7445.sabcs22-p1-09-05 Reprint of: de novo neuroendocrine features in prostate cancer
Abdulfatah, E,
Fine, SW,
Lotan, TL,
Mehra, R,
Hum Pathol, 2023 Mar; DOI:10.1016/j.humpath.2023.02.009 Molecular Characterization of Multifocal Granular Cell Tumors.
Dehner, CA,
Schroeder, MC,
Lyu, Y,
Bell, R,
Borcherding, DC,
Moon, T,
Hirbe, A,
Chrisinger, JSA,
Am J Surg Pathol, 2023 Mar; DOI:10.1097/PAS.0000000000001992 The impact of clinical trial enrollment on specialty palliative care utilization in pediatric patients with high-grade gliomas
Roberts, HJ,
Wang, Y,
Spruit, JL,
Taylor, L,
Franson, AT,
Pediatr Blood Cancer, 2023 Mar; DOI:10.1002/pbc.30115 Molecular testing in melanoma for the surgical pathologist
Pathology, 2023 Mar; DOI:10.1016/j.pathol.2022.12.343 Impact of a cell cycle and an extracellular matrix remodeling transcriptional signature on tumor progression and correlation with EZH2 expression in meningioma
Pereira, BJA,
Marcondes Lerario, A,
Sola, PR,
Laurentino, TDS,
Mohan, DR,
de Almeida, AN,
Pires de Aguiar, PH,
da Silva Paiva, W,
Wakamatsu, A,
Teixeira, MJ,
Oba-Shinjo, SM,
Marie, SKN,
J Neurosurg, 2023 Mar; DOI:10.3171/2022.7.JNS22953 Developing H3K27M mutant selective radiosensitization strategies in diffuse intrinsic pontine glioma
Parsels, LA,
Wahl, DR,
Koschmann, C,
Morgan, MA,
Zhang, Q,
Neoplasia, 2023 Mar; DOI:10.1016/j.neo.2023.100881 Prediction of Gastrointestinal Tract Cancers Using
Longitudinal Electronic Health Record Data
Read, AJ,
Zhou, W,
Saini, SD,
Zhu, J,
Waljee, AK,
Cancers (Basel), 2023 Feb; DOI:10.3390/cancers15051399 Longitudinal Electronic Health Record Data
Outcomes with immune checkpoint inhibitor (ICI) therapy in patients with FGFR2/3 alterations in advanced urothelial carcinoma (aUC).
Talukder, R,
Bakaloudi, DR,
Makrakis, D,
Tripathi, N,
Agarwal, N,
Jindal, T,
Koshkin, VS,
Johnson, J,
Zakharia, Y,
Brown, J,
Rey-Cárdenas, M,
Castellano, D,
Alva, AS,
Zakopoulou, R,
Korolewicz, J,
Drakaki, A,
Barata, PC,
Grivas, P,
Khaki, AR,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.478 Final results of phase Ib/II study of durvalumab and guadecitabine in advanced clear cell renal cell carcinoma (ccRCC) and biomarker analysis.
Zakharia, Y,
Singer, EA,
Acharyya, S,
Garje, R,
Joshi, M,
Peace, DJ,
Baladandayuthapani, V,
Laancette, C,
Kryczek, I,
Zou, W,
Alva, AS,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.696 Outcomes Database to Prospectively Assess the Changing Therapy Landscape in Renal Cell Carcinoma (ODYSSEY RCC).
Harrison, MR,
Bhavsar, NA,
Ged, Y,
Alva, AS,
Zakharia, Y,
Wong, RL,
Costello, BA,
Maughan, BL,
Monk, P,
Sinha, S,
Kilari, D,
Jabusch, S,
Zhang, T,
Scales, CD,
George, DJ,
Wulff-Burchfield, EM,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.tps739 Dissecting the molecular signatures underlying hybrid oncocytic tumors in Birt-Hogg-Dubé syndrome.
Wang, X,
Mannan, R,
Zhang, Y,
Hogan, M,
King, D,
Chinnaiyan, A,
Chinnaiyan, A,
Dhanasekaran, S,
Mehra, R,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.707 Evaluating the clinical utility of circulating tumor cells (CTC) profiling to predict selection of preferred therapeutic regimens in newly diagnosed or pretreated refractory renal cell carcinomas (RCC).
Vaishampayan, UN,
Taylor, JM,
Alva, AS,
Shah, N,
Mhalsekar, A,
Gosavi, RA,
Apurwa, S,
Patil, D,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.717 Clinical implications of Wnt signaling alterations in patients (pts) with advanced prostate cancer (aPC).
Broderick, A,
Li, J,
Chu, A,
Hwang, C,
Barata, PC,
Cackowski, FC,
Labriola, M,
Ghose, A,
Bilen, MA,
Kilari, D,
Graham, L,
Tripathi, A,
Garje, R,
Koshkin, VS,
Pan, E,
Dorff, TB,
McKay, RR,
Schweizer, MT,
Alva, AS,
Armstrong, AJ,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.229 Biomarkers of response to enfortumab vedotin (EV) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of the UNITE study.
Jindal, T,
Kilari, D,
Alhalabi, O,
Nizam, A,
Khaki, AR,
Basu, A,
Barata, PC,
Bilen, MA,
Shah, S,
Zakharia, Y,
Milowsky, MI,
Bellmunt, J,
Emamekhoo, H,
Davis, NB,
Grivas, P,
Gupta, S,
Hoimes, CJ,
Campbell, MT,
Alva, AS,
Koshkin, VS,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.450 Clinical impact of mutations in driver oncogenes and TP53/RB1 in advanced prostate cancer.
Hammer, L,
Rebernick, R,
McFarlane, M,
Westbrook, T,
Hazime, M,
Hammoud, T,
Chiu, P-E,
Xavier, O,
Wu, Y-M,
Robinson, DR,
Spratt, DE,
Alva, AS,
Jackson, WC,
Reichert, ZR,
Alumkal, JJ,
Chinnaiyan, A,
Cieslik, M,
Dess, RT,
Journal of Clinical Oncology, 2023 Feb; DOI:10.1200/jco.2023.41.6_suppl.263 Partial differential equation-based inference of migration and proliferation mechanisms in cancer cell populations
Kinnunen, PC,
Srivastava, S,
Wang, Z,
Ho, KKY,
Humphries, BA,
Chen, S,
Linderman, JJ,
Luker, GD,
Luker, KE,
Garikipati, K,
2023 Feb; DOI:10.48550/arxiv.2302.09445 Optimizing active surveillance for prostate cancer using partially observable Markov decision processes
Li, W,
Denton, BT,
Morgan, TM,
European Journal of Operational Research, 2023 Feb; DOI:10.1016/j.ejor.2022.05.043 Intersection of immune and oncometabolic pathways drives cancer hyperprogression during immunotherapy
Li, G,
Choi, JE,
Kryczek, I,
Sun, Y,
Liao, P,
Li, S,
Wei, S,
Grove, S,
Vatan, L,
Nelson, R,
Schaefer, G,
Allen, SG,
Sankar, K,
Fecher, LA,
Mendiratta-Lala, M,
Frankel, TL,
Qin, A,
Waninger, JJ,
Tezel, A,
Alva, A,
Lao, CD,
Ramnath, N,
Cieslik, M,
Harms, PW,
Green, MD,
Chinnaiyan, AM,
Zou, W,
Cancer Cell, 2023 Feb; DOI:10.1016/j.ccell.2022.12.008 Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2
Owen, DH,
Singh, N,
Ismaila, N,
Blanchard, E,
Celano, P,
Florez, N,
Jain, D,
Leighl, NB,
Mamdani, H,
Masters, G,
Moffitt, PR,
Naidoo, J,
Phillips, T,
Riely, GJ,
Robinson, AG,
Schenk, E,
Schneider, BJ,
Sequist, L,
Spigel, DR,
Jaiyesimi, IA,
J Clin Oncol, 2023 Feb; DOI:10.1200/JCO.22.02124 Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline, Version 2022.2.
Owen, DH,
Singh, N,
Ismaila, N,
Blanchard, E,
Celano, P,
Florez, N,
Jain, D,
Leighl, NB,
Mamdani, H,
Masters, G,
Moffitt, PR,
Naidoo, J,
Phillips, T,
Riely, GJ,
Robinson, AG,
Schenk, E,
Schneider, BJ,
Sequist, L,
Spigel, DR,
Jaiyesimi, IA,
J Clin Oncol, 2023 Feb; DOI:10.1200/JCO.22.02121 